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SUMMARY
The purpose of this study was to investigate the metabolic and cardiorespiratory effects of the administration of vecuronium under controlled
mechanical ventilation versus spontaneous ventilation in horses. Twenty healthy horses scheduled to elective surgery were randomized and
assigned in two groups. All animals were pre-medicated with romifidine (100 mg/kg iv), anesthesia was induced with an association of
tiletamine-zolazepam (2 mg/kg iv) and was maintained with halothane. Animals of group I remained in spontaneous ventilation without
muscle relaxation while group II received vecuronium (0.1 mg/kg IV) and was submitted to controlled mechanical ventilation. Vecuronium
administration did not cause any significant change of heart rate or rhythm, central venous pressure and arterial pressure. With the animals
that remained under spontaneous ventilation, no differences were observed in these parameters. The animals that received vecuronium
showed lower values of PaCO2 and normal values of pH in relation to the spontaneous ventilation group. Vecuronium duration was 12.83 ±
1.72 minutes. After halothane discontinuation the weaning time in group I I was 6.09 minutes with mean final PaCO2 values of 50.78
mmHg. There was no need of pharmacological reversion of vecuronium effect and recovery from anesthesia was similar in the two groups.
In conclusion, the use of mechanical controlled ventilation and vecuronium in horses is easily performed, does not induce further cardiovascular
depression and should be employed in equines undergoing major operations.
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INTRODUCTION
echanical ventilation nowadays is routinely employed
during general anesthesia. The use of this procedure is
largely justified due to many undesirable physiological
alterations caused by anesthesia in spontaneous breathing subjects.
The main alterations described during general anesthesia are:
depression of the respiratory center due to the use of anesthetic drugs,
oxygenation disturbances due to atelectasis and ventilation/perfusion
mismatching, hypercapnia, and metabolic acidosis. In the
anesthetized animal mechanical ventilation permits the respiratory
frequency, gas exchange and pulmonary compliance to return to
normal values and reduces respiratory work. In addition to this, the
recumbence during general anesthesia increases ventilation/perfusion
mismatch and decreases lung volume24,33. In the majority of the
anesthetized animals breathing spontaneously, the partial arterial
pressure of carbon dioxide (PaCO2) rises to values higher than 45
mmHg3,6. The gas exchange process is impaired, arterial hypoxaemia
occurs and a significant difference in the partial pressure of oxygen
from the alveolus to the arterial blood is always observed32,33,34. The
sound patient can tolerate these alterations, however, those suffering
important metabolic disturbances, due to the lack of physiological
reserves, are unable to compensate the respiratory alteration, which
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is aggravated by the use of drugs for induction and maintenance of
general anesthesia6,30.
Moreover, other injuries such as thoracic trauma, pneumo-
thorax, pleural effusion, pulmonary edema and diaphragmatic hernia,
may also contribute to worsen the alterations previously described.
This fact, reinforces the use of controlled ventilation during general
anesthesia1,2.
Controlled ventilation can be obtained in three different
ways: depressing ventilatory centers by hyperventilation thus
reducing PaCO2 below the level at which the horse is stimulated to
breathe, anesthesia deepening or use of neuromuscular blocking
agents13,28. Muscle relaxants are routinely used in human anesthesia,
to ease tracheal intubation and to allow smooth controlled mechanical
ventilation, avoiding unnecessary hyperventilation and deep levels
of anesthesia. Another important favourable point for the use of
neuromuscular blocking agents during mechanical ventilation is
related to the decrease of lung barotrauma incidence. Several studies
have demonstrated that lung parenchyma injury is due to excessive
volume ventilation20,23. A tidal volume higher than 10 ml/kg
associated to elevated respiratory frequency may cause air trapping,
alveoli injury and hemodynamic disturbances. The temptation to
overdrive the neural respiratory stimulus by hyperventilation, a
common way to induce apnea in animals, is a condemned practice
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in modern human mechanical ventilation. In equine Veterinary
Medicine, the neuromuscular blocking agents are mainly indicated
with the primary intention of promoting a better muscle relaxation
during specific procedures where muscle relaxation is mandatory
as seen in orthopedic and ophtalmologic surgery9,17.
Among the new adespolarizing neuromuscular blocking
agents, vecuronium is characterized to be more potent and to have a
rapid onset and shorter duration of action than pancuronium. In
addition to its cardiovascular stability and absence of deleterious
effects on kidneys and liver, no cardiac muscarinic receptors blockage
and no histamine release are observed with the use of this agent.
Another interesting characteristic described during vecuronium
utilization is the infrequent possibility of residual blockage7,15,16.
Vecuronium excretion is done by kidneys and liver. However renal
failure has little influence on its depuration15. This means that the
end of its action is less dependent of renal function. This vecuronium
property could be an advantage on patients with nephropathies.
Hepatic diseases however, jeopardize its elimination, because 50%
of the administered drug dosage is excreted through the billiary
route21. The knowledge about vecuronium in the horse is limited,
but a dose of 0.1 mg/kg produces neuromuscular blockage of 20 -
30 minutes8. Similar to other agents frequently used in horses, the
effect of vecuronium can be reverted by the use of neostigmine3,10,19.
In dogs vecuronium is the muscle relaxant with fewer undesirable
effects on the cardiovascular system, not affecting cardiac output,
arterial pressure and central venous pressure7,16. Another advantage
of this agent in this species could be its short duration of action and
limited cumulative effects that could minimize or even eliminate
the incidence of residual weakness during the recovery phase and
the need of antagonists such as neostigmine15. The purpose of this
study is to evaluate the metabolic and cardiorespiratory effects of
mechanical controlled ventilation in horses paralyzed by vecuronium.
MATERIAL AND METHOD
This study is based on the observations done on 20 sound
horses scheduled to routine surgery, 18 of those where male and 2
females. The horses were of different breeds, with ages varying from
2 to 8 years and bodyweight varying from 300 to 476 kg.
The animals were pre-medicated with romifidine (Sedivet,
Boehringer Ingelheim, Brazil) (100 ug/kg iv) through a 16-gauge
catheter placed percutaneously into the jugular vein. After 15
minutes, an association of tiletamine-zolazepam (Zoletil, Virbac do
Brasil) (2 mg/kg iv) was given. Once the animal was recumbent,
orotracheal intubation was performed and the animals connected to
a large animal carbon dioxide absorption circuit in a semi closed
system (Matrix VML, Large Animal Absorber Circuit, USA).
Anesthesia was maintained with halothane (Halotano, Hoechst do
Brasil S.A.) in 100% oxygen using an out-of circle halothane
precision vaporizer, at a concentration high enough to keep an
adequate level of surgical anesthesia (regular assessment of the
palpebral and corneal reflexes). Afterwards the animals were
randomly assigned to two groups: Group I - animals were kept in
spontaneous ventilation and Group II - after 15 minutes of the
beginning of inhalation anesthesia the horses received vecuronium
(Norcuron - Labs. Organon do Brasil Ltda.) (0.1 mg/kg iv). While
the total paralyzing effect was not achieved, ventilatory support was
started by manually triggering the demand valve of the anesthetic
machine at least tree times. Once the respiratory movements had
ceased, the animals were set on controlled ventilation using a volu-
me-limited/time-cycled ventilator (Rachel Model 2800 - Large Ani-
mal Anesthesia Ventilator - Mallard Medical, USA) designed for
large animals. The respiratory rate was established at 9 to 10
respiratory movements per minute, inspiratory time at 2 seconds,
inspiratory: expiratory rate 1:2.5. Tidal volume was initially
estimated on 10 ml/kg and adjusted to maintain the PaCO2 between
40 and 50 mmHg. Peak inspiratory pressure remained between 20
and 30 cm H2O. At the end of operation the anesthetic inhalation
was turned off, the weaning of controlled ventilation was done by
gradually reducing the respiratory frequency with the intention of
increasing the PaCO2 thus stimulating the respiratory center and
observing the presence of spontaneous respiratory movements. Before
extubation the adequacy of the respiratory function was checked
evaluating if the inspiratory force was good enough to provide
adequate tidal volume during the exhalation, verified through the
bellows movements to a normal range. This findings allowed to
indicate or not the necessity of pharmacological antagonism of the
neuromuscular blocking agent.
The parameters evaluated during the experiment were: heart
rate and rhythm, arterial systolic and diastolic pressure, respiratory
rate, oxyhemoglobin saturation, central venous pressure, blood ga-
ses and also blood pH and HCO3-. These parameters were evaluated
as follows: cardiac rate and rhythm continuously on an oscilloscope
(Dixtal 910 - Dixtal, Brazil); the arterial pressure directly through
catheterization of the facial artery and connection to the pressure
transducer (Biomonitor, Bese, Brazil); respiratory frequency through
observation of thoracic wall movements during 1 (one) minute;
oxyhemoglobin saturation by pulse oximetry (Modell 3100, BCI -
Biochen International, USA) with the transducer positioned at the
tip of the tongue, central venous pressure (CVP) through
catheterization of the jugular vein and animals were in lateral
recumbence. Blood samples for blood gas, pH and HCO3- analysis
were obtained anaerobically through the catheter placed at the facial
artery. The examination of the blood samples was done in a pH and
gas analyzer (Gasometer ABL 330, Radiometer, Denmark),
immediately after blood sampling.
The parameters were evaluated at the following moments:
immediately before and 15 minutes after romifidine administration;
15, 30, 45 minutes after beginning of anesthetic maintenance with
halothane and after recovery of spontaneous breathing. The
evaluation of the onset of action of vecuronium was done by observing
the cessation of respiratory movements. The criteria used to evaluate
the cessation of vecuronium’s action was observation of spontaneous
palpebral movements and rotation of the ocular globe back to a
forthmedial position.
The quality of the anesthetic recovery was evaluated by
observing the presence or absence of: excitation, significant muscu-
lar tonus, motor incoordenation, sudden movements of head and
limbs, number of times the animals tried to stand up and if they
were able to remain standing. The recovery time was measured from
the time the animal was extubated until it managed to stand straight
on its own.
The results were statistically analyzed by parametric
examination. Analysis of variance (ANOVA), followed by the
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Tukey-Kramer test for comparison of the different observation
moments of the same group were used. The Student-Newman-
Keuls test was used to evaluate possible differences between the
two groups. Significance was considered as p<0.05. Both statistical
analysis were done by computer program (INSTAT, Graphpad
Software, USA).
Table 1
Metabolic and cardiorespiratory data of animals submitted to spontaneous ventilation (Group I) versus controlled ventilation (group II). São
Paulo, 1995.
HR - heart rate; RR - respiratory rate; SAP - systolic arterial pressure; DAP - diastolic arterial pressure; CVP - central venous pressure;
PaCO2 - partial pressure of carbon dioxide; PaO2 - partial pressure of oxygen; HCO3- - plasma bicarbonate level; SaO2
 
- oxyhemoglobin
saturation on arterial blood; SpO2 - oxyhemoglobin saturation by pulse oxymeter. * significantly different (p<0.05) - group I in relation to
group II.
rate, expressed in mean values and SD of mean are described in
Tab. 1. A significant decrease of heart rate was verified in both
experimental groups after romifidine administration. During
halothane anesthesia the heart rate was similar to base line values.
The injection of vecuronium did not cause any alteration of the
cardiac rhythm or rate. A significant reduction of arterial systolic
and diastolic pressure after administration of the inhalatory agent,
was noticed in both groups, with no return to normal values until
the end of the recording period. During the experiment central
venous pressure remained unchanged.
In comparison to the respiratory rate before anesthesia, both
groups had inferior values during inhalatory anesthesia. Values
obtained after romifidine administration in horses of group II were
also significantly greater than those values verified during halothane
anesthesia but inferior to animals of group I. Animals that remained
in spontaneous ventilation, showed a significant decrease of
respiratory rate at 30 and 45 minutes, in relation to those animals
that had controlled ventilation.
The pH of the animals of group I decreased during the
course of inhalatory anesthesia, with no restoration of base values.
In group II the values decrease only during the first 15 minutes of
the inhalatory anesthetic procedure. When controlled ventilation
was performed, theses values returned to the pre-anesthetic values.
RESULTS
No differences related to age and weight between the
animals of the two groups were verified. The surgical procedures
had a mean duration of sixty minutes. The administration of the
pre-anesthetic drug caused the expected effects on heart rate and
rhythm. A significant decrease of heart rate was observed after
romifidine administration in both groups. Mobitz type-I second-
degree atrioventricular (AV) block was observed in 7 horses of
group I and in 8 animals of group II; Mobitz type-II second-
degree AV block occurred in 2 animals of group I and 1 animal
of group II; First-degree AV block was observed in 1 animal of
group I and sinoatrial block was diagnosed in 1 horse of group
II. After the administration of the tiletamine-zolazepan associa-
tion the normal sinus rhythm was reestablished. All data of heart
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In both groups the PaO2 increased after administration of 100%
oxygen. Animals of the 2nd group reached higher PaO2 values than
animals of the first group. The PaCO2 increased considerable during
the inhalatory anesthesia procedure in animals of group I, not
returning to pre-anesthetic values. In the animals of group II however
a rise in PaCO2
 
values occurred only at 15 minutes after the esta-
blishment of inhalatory anesthesia, recovering baseline values during
controlled ventilation and increasing again after re-establishment
of spontaneous ventilation (Fig. 1). Only at 45 minutes after the
begin of inhalatory anesthesia both groups showed significant
difference of the HCO3- values. The oxyhemoglobin saturation in
arterial blood, increased in both groups since 100% oxygen was
used. There was a significant difference in values obtained by pulse
oximetry and those of the arterial blood.
The time period necessary for apnea establishment was 2.5
± 0.5 minutes. The duration of action of vecuronium was 12.83 ±
1.72 minutes.
Concerning the anesthetic recovery, only 3 animals (one of
group I and two of group II) made more than one attempt to stand
up, before assuming the standing position. These three animals
assumed a position in which they stood on their rear leg toes, showing
strong contraction of the hindlimb muscles. The time taken by the
animals to stand up was 34.12 ± 12.07 minutes for animals of group
I and 29.25 ± 9.37 minutes for animals of group II and the difference
was not statistically significant. Three animals of group I and four
animals of group II made violent attempts to get out from the recovery
room when they stood up but until that moment no signs of
excitement were observed.
DISCUSSION
Uncountable clinical situations require the use of ventilatory
assistance, in order to improve tissue oxygenation and/or to remove
carbon dioxide. The use of mechanical ventilation is frequently
necessary, when drugs, specially during general anesthesia, have a
negative effect on the respiratory system impairing gas exchanges
in the lungs. Yet, even if improving oxygenation, the use of ven-
tilatory assistance may cause hemodynamic embarrassment25. The
cardiovascular depression observed during controlled ventilation is
caused by multifactorial effects most of them due to mechanical
restraint of venous return, caused by the positive pressure on lungs
and thorax. In addition to this mechanical factor, excessive reduction
of carbon dioxide achieved with this kind of ventilation, decreases
circulating cathecolamines25.
Concerning the observed cardiovascular variations,
hypotension was verified during inhalatory anesthesia, in both
groups of this study. Romifidine produces cardiovascular
depression, characterized by bradicardia and hypertension which
is followed by persisting hypotension4,5. The association of
tiletamine-zolazepam, used to induce anesthesia, does not deter-
mine cardiovascular depression. The ability of cyclohexamines
(ketamine, tiletamine) to maintain cardiac function and arterial
blood pressure by a variety of different mechanisms is well
known36. Hubbel et al.12 evaluated the association of tiletamine-
zolazepan (2.2 mg/kg IV) in horses pre-medicated with xylazine
(1.1 mg/kg IV) and verified a significant decrease in arterial
blood pressure after xylazine administration that was not
intensified or modified by the injection of the tiletamine-
zolazepan association. In the same way, Vecunorium does not
cause any undesirable effects on the cardiovascular system15. In
dogs this agent does not promote any significant change in arte-
rial blood pressure16. Hackett et al. noticed an increase in cardiac
output and systolic volume as well as a decrease in pulmonary
vascular resistance after vecuronium. However halothane, the
inhalatory anesthetic, causes an important reduction of
myocardial contractility, decreasing cardiac output, left ventri-
cular work and systemic arterial pressure30. Considering the
previous reports mentioned above on the effects of the drugs used
in this study and the results obtained in both experimental groups,
we may suppose that the bradicardia and hypotension noticed
here are related to the use of romifidine and halothane. In the
present study the decrease in arterial pressure in the animals of
group II was similar to the variation noticed in the group I.
Coincidentally to the observations of Steffey; Howland31 and
Hodgson et al.11, the decrease in arterial pressure in our study
may be attributed to the halogenated agent, instead of the
ventilation mode employed in the animals.
Hypoventilation characterized by hypercapnia, hypoxia
and respiratory acidosis is a common complication during horse
anesthesia, specially when kept on spontaneous venti-
lation6,13,18,30,32. Various assumptions were theorized to explain
the hypoventilation observed during general anesthesia in this
species. The fact that the animal assumed lateral or dorsal
recumbence was for long thought to be the principal cause of
respiratory malfunctions noticed during general anesthesia. Many
studies done on anesthetized horses reinforce the deleterious
Figure 1
The solid line represents the PaCO2 values of animals of group I. The
dash line represents the PaCO2 values of animals submitted to controlled
ventilation (group II); mean ± s.d.
CV - control values;
* group I presented significant higher levels of PaCO2 when compared
to control values and to the group II at the same time (p<0.05);
** both groups presented significant higher values of PaCO2
 
when
compared to control values (p<0.05).
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effects of recumbence on respiratory function24,32,33. Unfavorable
blood flow distribution in the lung that remains in a ventral
position is observed and is due mostly to mechanical forces. As a
result of the increase in pleural pressure a reduction of pulmonary
volume occurs24. An augmentation in the pulmonary shunt, that
can reach values up to 51% and an increase of alveolar-arterial
oxygen difference is observed34. Rugh et al.26 pointed out that
the effects of lateral recumbence on PaO2 and PaCO2 are to be
accounted to the depression caused by anesthetic agents used
during the procedure with no relation to the recumbence alone.
In fact Schatzmann et al.27 evaluating the effects of lateral and
dorsal recumbence in ponies given glycerol guaiacolate, did not
notice any difference concerning PaCO2, when comparing
animals in recumbence to those standing. Halothane and other
inhalatory anesthetics cause dose-dependent respiratory
depression, characterized by increase of PaCO2, decrease in the
capacity to oxygenate arterial blood and decrease in respiratory
rate29,31. Theses drugs also induce intense relaxation of respiratory
muscles and decrease the chemoreceptor sensitivity6,13,30.
Animals of group I showed hypercapnia and a marked
decrease of pH during inhalatory anesthesia as expected. The values
of PaCO2 of 58, 62 and 57 mmHg at 15, 30 and 45 minutes
respectively, are similar to those observed by Hubbel; Muir13, who
had mean PaCO2 values of 57.6 mmHg. Grandy et al.6 noticed
higher PaCO2 levels reaching 78.5 mmHg. The presence of
hypercapnia and low values of pH can be explained by the use of
halothane and the fact that animals were in lateral recumbence.
On the other hand, animals on mechanical ventilation showed
PaCO2 values of 46 and 44 mmHg at 30 and 45 minutes, values
close to the ones observed by Hubbel; Muir13, who had average
values of 45 mmHg during 60 minutes of controlled ventilation.
There was a significant difference between values of oxyhe-
moglobin saturation obtained by pulse oximetry and those obtained
at the arterial blood, the same results were obtained by Whitehair35.
The absence of accuracy of pulse oximeter was due to the kind of
the probe used in the tongue in this specie.
In this study the weaning time was 6.09 minutes with mean
PaCO2 values of 50.78 mmHg. Hubbel; Muir13 had a weaning time
of 3 minutes and PaCO2 of 65.8 mmHg. This difference is probably
due to the fact that in this study, the weaning time was considered
until animals had reassumed spontaneous ventilation with adequate
respiratory rate and amplitude.
Vecuronium had a neuromuscular blockage effect of 12.83
minutes against 20-30 mentioned by Hall; Clarke8. Despite the short
duration of action subsequent doses of vecuronium were not
necessary. The maintenance of adequate levels of PaO2, PaCO2 along
with the respiratory center depression caused by halothane may
explain this facts. The use of neostigmine to revert vecuronium effect
was not necessary as the animals were able to maintain a normal
tidal volume after weaning. This last observation is very important,
because the use of other blockage drugs such as pancuronium require
pharmacological antagonism3,14. Neostigmine may promote
undesirable effects like bradicardia, hypotension and increased
gastrointestinal motility even if atropine is administered19. Besides
that, unpredictable effects such as increase of blood pressure and
tachycardia may also occur10.
Vecuronium has shown to be an excellent agent to allow
smooth controlled ventilation in horses, preventing the animals from
fighting the ventilator and without promoting undesirable
cardiovascular effects such as tachycardia and hypertension commonly
verified with pancuronium in horses22. The use of controlled ventilation
in horses was easily performed and was not associated with
cardiovascular embarrassment during inhalatory anesthesia.
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RESUMO
O objetivo do presente estudo foi avaliar os efeitos metabólicos e respiratórios da administração de vecurônio em cavalos submetidos a
ventilação controlada e compará-los àqueles que permaneceram em respiração espontânea. Foram empregados vinte animais hígidos
alotados em dois grupos experimentais. Todos os animais foram pré-medicados com romifidina (100 mg/kg IV) sendo a anestesia
induzida com a associação de tiletamina-zolazepam (2 mg/kg IV) e a manutenção realizada com halotano. Os animais do grupo I
permaneceram em respiração espontânea enquanto os animais do grupo II receberam vecurônio na dose de 0,1 mg/kg IV sendo subme-
tidos a ventilação controlada mecânica. A administração do vecurônio não promoveu qualquer alteração significativa da freqüência ou
ritmo cardíaco, pressão venosa central ou pressão arterial. No atinente aos animais que permaneceram em respiração espontânea, não
houve qualquer diferença em relação a estes parâmetros quando comparados aos dos animais que permaneceram em respiração espon-
tânea. Os animais que receberam o vecurônio apresentaram valores inferiores de PaCO2 e valores normais de pH em relação aos animais
do grupo I. A duração de ação do vecurônio foi de 12,83 ± 1,72 minutos. Após o término da administração do halotano, os animais do
grupo II retornaram à ventilação espontânea em 6,09 minutos demonstrando valores de PaCO2 da ordem de 50,78 mmHg. Não houve
necessidade de reversão farmacológica do bloqueador e a qualidade da recuperação foi semelhante nos dois grupos. Frente aos resulta-
dos obtidos, pode-se concluir que o emprego de ventilação controlada mecânica e vecurônio em eqüinos é factível e isenta de efeitos
adversos, sendo portanto indicada nesta espécie.
UNITERMOS: Respiração Artificial; Brometo de vecurônio; Anestesia geral; Eqüinos.
FANTONI, D.T.; ALVARENGA, J.; SILVA, L.C.L.C.; CORTOPASSI, S.R.G.; MIRANDOLA, R.M.S. Controlled mechanical ventilation in horses under vecuronium
blockage. Braz. J. vet. Res. anim. Sci., São Paulo, v. 35, n. 4, p. 182-187, 1998.
187
REFERENCES
1- BEECH, J. Miscellaneous lung and pleural injuries. In: BEECH, J. Equine
respiratory disorders. Philadelphia : Lea & Febiger, 1991. p.215-21.
2- BOYSEN, P.G.; MODELL, J.H. Pulmonary edema. In: SHOEMAKER, P.R.;
GRENVIK, A.; AYRES, S. Textbook of critical care. 2.ed. Philadelphia :
W.B. Saunders, 1989. p.515-9.
3- CALDWELLL, J.E.; ROBERTSON, N.E.; BAIRD, W.L.M. Antagonism of profound
neuromuscular blockade induced by vecuronium or atracurium British Journal
of Anaesthesia, v.58, n.11, p.1285-9, 1986.
4- CLARKE, K.W.; ENGLAND, G.C.W; GOOSSENS, E.L. Sedative and car-
diovascular effects of romifidine alone and in combination with butorphanol, in
the horse. Journal of Veterinary Anaesthesia, v.18, n.2, p.25-30, 1991.
5- ENGLAND, G.C.W.; CLARKE, K.W.; GOOSSENS, E.L. A comparison of tree alpha
2-adrenoceptor agonists (romifidine, detomidine, xylazine) in horses. Journal of
Veterinary Pharmacology Therapeutics, v.15, n.2, p.194-201, 1992.
6- GRANDY, J.L.; STEFFEY, E.P.; MILLER, M. Arterial blood pO2 and pCO2 in
horses during early halothane-oxygen anaesthesia. Equine Veterinary Journal,
v.19, n.3, p.314-8, 1987.
7- HACKET, G.H.; JANTZEN, J.P.A.H.; EARNSSHAW, G. Cardiovascular effects of
vecuronium, atracurium, pancuronium, metocurine and RGH-4201 in dogs.
Acta Anaesthesiologica Scandinavica, v.33, n.4, p.298-303, 1989.
8- HALL, L.W.; CLARKE, K.W. Veterinary anaesthesia. London : Baillière Tindall,
1991. p.120.
9- HILDEBRAND, S.V.; HOLLAND, M.; COPLAND, V.S.; DAUNT, D.; BROCK,
N. Clinical use of the neuromuscular blocking agents atracurium and pancu-
ronium for equine anesthesia. Journal of the Veterinary Medical Association,
v.195, n.2, p.212-9, 1989.
10- HILDEBRAND, S.V.; HOWITT, G.A Antagonism of pancuronium neuromuscular
blockade in halothane-anesthetized ponies using neostigmine and edrophonium.
American Journal of Veterinary Research, v.45, n.11, p.2276-80, 1984.
11- HODGSON, D.S; STEFFEY, E.P.; GRANDY, J.L.; WOLINER, M.J. Effects of
spontaneous, assisted and controlled ventilatory modes in halothane-anesthetized
geldings. American Journal of Veterinary Research, v.47, n.5, p.992-6, 1986.
12- HUBBELL, J.A.E.; BEDNARSKI, R.M.; MUIR, W.W. Xylazine and tiletamine-
zolazepam anesthesia in horses. American Journal of Veterinary Research,
v.50, n.3, p.731-41, 1989.
13- HUBBELL, J.A.E.; MUIR, W.W. Rate of rise of arterial carbon dioxide tension in
the halothane anesthetized horse. Journal of the American Veterinary Medical
Association, v.186, n.5, p.374-6, 1985.
14- HUNTER, J.M. Resistence to non-depolarizing neuromuscular blocking agents.
British Journal of Anaesthesia, v.67, n.5, p.511-4, 1991.
15- HUNTER, J.M.; JONES, R.S.; UTTING, J.E. Comparison of vecuronium,
atracurium and tubocurarine in normal patients and patients with no renal
function. British Journal of Anaesthesia, v.56, n.9, p.941-56, 1984.
16- JONES, R.S. Neuromuscular blocking action of vecuronium in the dog and its reversal
by neostigmine. Research in Veterinary Science, v.38, n.2, p.193-6, 1985.
17- KALHORO, A.B.; REX, M.A.E. The dose rate of pancuronium bromide for horses.
Australian Veterinary Journal, v.60, n.11, p.348-9, 1983.
18- KARIMI, A. Comparison of the effects of two sets of anesthetic agents and posture
on respiratory rate, heart rate, pH, blood gas and acid-base status in the horse.
British Veterinary Journal, v.67, n.6, p.506-10, 1987.
19- KLEIN, L.; HOPKINS, J.; BECK, E.; BURTON, B. Cumulative dose response to
gallamine, pancuronium, and neostigmine in halothane-anesthetized horses:
neuromuscular and cardiovascular effects. American Journal of Veterinary
Research, v.44, n.5, p.786-92, 1983.
20- KOLOBOW, T.; MORETTI, M.P.; FUMAGALLI, R. Severe impairment in lung
function induced by peak airway pressure during mechanical ventilation.
American Review Respiratory Disease, v.135, n.2, p.312-5, 1987.
21- LEBRAULT, C.; BERGER, J.L.; D’HOLLANDER, A.A.; GOMENI, R.;
HENZEL, D.; DUVALDESTIN, P. Pharmacokinetics and pharmacodinamics
of vecuronium (ORG NC 45) in patients with cirrhosis. Anesthesiology, v.62,
n.5, p.601-5, 1985.
22- MANLEY, S.V.; STEFFEY, E.P.; HOWITT, G.A; WOLINER, M. Cardiovascular
and neuromuscular effects of pancuronium bromide in the pony. American of
Journal Veterinary Research, v.44, n.7, p.1349-53, 1983.
23- MASCHERONI, M.; KOLOBOW, T.; FUMAGALLI, R. Acute respiratory failure
following pharmacologically induced hyperventilation: an experimental animal
study. Intensive Care Medicine, v.15, n.1, p.8-14, 1988.
24- MCDONELL, W.N.; HALL, L.W.; JEFFCOTT, L.B. Radiographic evidence of
pulmonary function in laterally recumbent anaesthetized horses. Equine
Veterinary Journal, v.11, n.1, p.24-32, 1979.
25- PEREL, A.; PIZOV, R. Cardiovascular effects of mechanical ventilation. In: PEREL,
A.; STOCK, M.C. Mechanical ventilatory support. Baltimore : Williams &
Wilkins, 1992. p.51-65.
26- RUGH, K.S.; GARNER, H.E.; HATFIELD, D.J.; HERROLD, D. Arterial oxygen
and carbon dioxide tensions in conscious laterally recumbent ponies. Equine
Veterinary Journal, v.16, n.3, p.185-8, 1984.
27- SCHATZMANN, U.; KOEHI, M.; DUDAN, F.; ROHR, W.; JONES, R.S. Effect
of postural changes of certain circulatory and respiratory values in the horse.
American Journal of Veterinary Research, v.43, n.6, p.1003-5, 1982.
28- SHAWLEY, R.V.; MANDSAGER, R.E. Clinical use of positive-pressure ventilation
in the horse. Veterinary Clinics North America- Equine Practice, v.6, n.3,
p.575-85, 1990.
29- STEFFEY, E.P. Enflurane and isoflurane anesthesia: a summary of laboratory and
clinical investigation. Journal of the American Veterinary Medical Asso-
ciation, v.172, n.3, p.367-5, 1978.
30- STEFFEY, E.P. Inhalation anesthetics and gases. In: MUIR, W.W.; HUBBEL, J.A.E.
Equine anesthesia. St Louis : Mosby Year Book, 1991. p.366-79.
31- STEFFEY, E.P.; HOWLAND, J.R. Cardiovascular effects of halothane in the horse.
American Journal of Veterinary Research, v.39, n.4, p.611-5, 1978.
32- STEGMANN, G.P. Pulmonary function in the horse during anesthesia: a review.
Journal of the South African Veterinary Association, v.57, n.1, p.49-53,
1986.
33- STEGMANN, G.F.; LITTLEJOHN, A. The effect of lateral and dorsal recumbency
on cardiopulmonary function in the anaesthetized horse. Journal of the South
Africa Veterinary Association, v.58, n.1, p.21-7, 1987.
34- WEAVER, B.M.Q.; WALLEY, R.V. Ventilation and cardiovascular studies during
mechanical controlled ventilation in horses. Equine Veterinary Journal, v.5,
n.1, p.9-15, 1975.
35- WHITEHAIR, K.J. Pulse oximetry in horses. Veterinary Surgery, v.19, n.3, p.243-
8, 1990.
36- WRIGHT, M. Pharmacologic effects of ketamine and its use in veterinary medicine.
Journal of the American Veterinary Medical Association, v.180, n.12,
p.1462-71, 1982.
Received: 11/04/1997
Accepted: 07/11/1997
